SCHEMBL4289310

SCHEMBL4289310

Nc1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)nc1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
HPGD P15428 3/20 0.37
TSHR P16473 1/20 0.37
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
MAPT P10636 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KMT2A Q03164 3/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP2C9 P11712 1/20 0.34
AURKA O14965 1/20 0.34
APP P05067 1/20 0.33
ADORA1 P30542 1/20 0.33
CYP1A2 P05177 2/20 0.32
HIF1A Q16665 1/20 0.32
MAPK1 P28482 1/20 0.32
GRN P28799 1/20 0.32
SORT1 Q99523 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4285291 0.84 TP53 (0.44) ALDH1A1HPGDTSHRMAPTSMN1; SMN2
SCHEMBL27815941 0.78 PTGER1 (0.40) ALDH1A1HPGDTSHRMAPTSMN1; SMN2
SCHEMBL27815920 0.77 ALDH1A1 (0.34) ALDH1A1HPGDTSHRMAPTSMN1; SMN2
SCHEMBL4289358 0.76 RAB9A (0.41) ALDH1A1HPGDTSHRMAPTKMT2A
SCHEMBL34473961 0.72 POLB (0.40) ALDH1A1HPGDTSHRPTGS1MAPT
SCHEMBL20366997 0.71 CYP2C9 (0.56) ALDH1A1HPGDTSHRMAPTSMN1; SMN2
SCHEMBL28916204 0.71 KDM4E (0.42) ALDH1A1HPGDTSHRMAPTSMN1; SMN2
SCHEMBL3846829 0.69 GAA (0.44) ALDH1A1TSHRMAPTSMN1; SMN2KMT2A
SCHEMBL28916239 0.69 MAPT (0.43) ALDH1A1TSHRMAPTSMN1; SMN2KDM4E
SCHEMBL3147317 0.69 GABRP (0.40) ALDH1A1HPGDMAPTKDM4EHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156582-A1 Pyrazole Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-18 US disclosed
EP-1847531-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156582-A1 Pyrazole Compound GSK3B, GSK3A, GSKIP ALDH1A1 694/4885HPGD 2563/4885TSHR 2251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.